Literature DB >> 32226758

Histoplasmosis of the gallbladder.

Cassidy Claassen1, Christopher Grove2, Paul Saleeb1.   

Abstract

Histoplasmosis of the gallbladder is an extremely rare condition. We present the case of cholecystitis due to progressive, disseminated histoplasmosis in an immunocompetent woman.
© 2019 The Authors.

Entities:  

Keywords:  Gallbladder; Histoplasmosis

Year:  2019        PMID: 32226758      PMCID: PMC7093749          DOI: 10.1016/j.idcr.2019.e00666

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


A 33-year-old woman with history of seizure disorder and thyroidectomy for papillary adenocarcinoma was hospitalized following a seizure resulting in a motor vehicle accident (MVA). Radiologic imaging revealed no fractures; however, CT imaging demonstrated innumerable hypodense lesions in her liver and spleen. Following discharge, she underwent a liver biopsy that demonstrated non-necrotizing granulomata; bacterial, mycobacterial, and fungal staining of the tissue revealed no organisms. She remained asymptomatic and underwent serial imaging of her abdomen, during which time the lesions remained unchanged in size and number. Four years later, she developed biliary colic and underwent a cholecystectomy. Histopathology revealed chronic inflammation in the gallbladder. A cystic duct lymph node contained a necrotizing granuloma (Fig. 1), and fungal elements consistent with histoplasmosis were seen with Gomori Methenamine-Silver (GMS) staining (Fig. 2).
Fig. 1

Cystic duct lymph node with necrotizing granuloma.

Fig. 2

Gomori Methenamine-Silver (GMS) stain of cystic duct lymph node with fungal elements consistent with histoplasmosis.

Cystic duct lymph node with necrotizing granuloma. Gomori Methenamine-Silver (GMS) stain of cystic duct lymph node with fungal elements consistent with histoplasmosis. The patient was referred to our clinic for management of disseminated histoplasmosis. Further querying revealed that she had been experiencing intermittent fevers, night sweats, and weight loss for months preceding the cholecystectomy. She also reported that prior to the MVA she had lived in a house that had a severe bat infestation and abundant guano. Additional workup included a chest CT that showed numerous pulmonary calcifications and a brain MRI that did not reveal any lesions. Of note, her Histoplasma serum antibodies were only reactive at a 1:1 dilution, consistent with chronic infection, and urine Histoplasma antigen was negative. She was treated with itraconazole for 24 months, during which time her symptoms completely resolved. Disseminated histoplasmosis is commonly associated with pulmonary, hepatic, and splenic involvement. Infiltration of the gallbladder, though, is an extremely rare manifestation of disease—even in immunocompromised hosts. Instances of acalculous cholecystitis due to histoplasmosis in HIV-infected individuals histoplasmosis have been described in the literature [1,2]. To the best of our knowledge, this is the first published case describing cholecystitis in an immunocompetent individual. Our patient likely developed progressive disseminated histoplasmosis in her lungs, liver, and gallbladder due to her prolonged co-habitation with bats.

Authors’ contribution

Drs. Claassen and Saleeb contributed equally in the clinical management of this patient and in writing the case presentation. Dr. Grove obtained and processed the clinical images and provided a histopathologic interpretation of them.

Funding source

There is no funding source for this manuscript.

Declaration of Competing Interest

None.
  2 in total

1.  Acalculous Cholecystitis caused by Histoplasma capsulatum in a severely immunosuppressed HIV-infected patient.

Authors:  Jorge Alave; Beatriz Bustamante; Leslie Soto; Jaime Caceres; Carlos Seas
Journal:  J Infect Dev Ctries       Date:  2011-03-21       Impact factor: 0.968

2.  Acalculous Cholecystitis Due to Histoplasma capsulatum in a Patient With HIV Infection.

Authors:  Takashi Shinha; Gary Zabarsky
Journal:  ACG Case Rep J       Date:  2015-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.